Chronic Pain Gene Discovery Could Mean New Medication

Scientists have discovered how the gene HCN2 causes chronic neuropathic pain, clearing the way for possible development of a drug to reduce pain by blocking a protein the gene produces, according to a University of Cambridge news release.

Advertisement

 

Scientists at the University of Cambridge in England studying the HCN2 gene, which is expressed in pain-sensitive nerve endings, have published their findings in the journal Science.

 

Engineering the removal of the HCN2 gene from pain-sensitive nerves in mice, researchers carried out studies using electrical stimuli on these nerves in cell cultures to determine how their properties were affected.

 

Related Articles on Chronic Pain:

Evidence Found on how Meditation Relieves Pain

FDA Approves Tapentadol for Chronic Pain

New Form of Nasal Administration Could Improve Response to Pain Drugs


 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.